NCT00440895 - A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI and Rescue-PCI | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2012

Study Completion Date

May 31, 2013

Conditions

Myocardial InfarctionIschemia

Interventions

DRUG

Abciximab

Abciximab (bolus) i.c. or i.v. or placebo, bolus dose is calculated according to current dosage (0.25 mg/kg) followed by 12 h infusion at 0.125 µg/kg/min (max 10µg/min).

Trial Locations (1)

G1V 4G5

Laval Hospital, Québec